| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,969 |
15,212 |
$2.35M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,098 |
8,012 |
$1.54M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14,164 |
10,314 |
$1.39M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
9,890 |
2,303 |
$1.02M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,431 |
7,559 |
$961K |
| 80053 |
Comprehensive metabolic panel |
26,268 |
21,356 |
$453K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,058 |
826 |
$409K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,036 |
3,466 |
$279K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,977 |
1,834 |
$195K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
13,771 |
8,804 |
$184K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,375 |
745 |
$106K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
420 |
339 |
$99K |
| 83605 |
|
3,740 |
3,041 |
$98K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,084 |
939 |
$96K |
| 70450 |
Computed tomography, head or brain; without contrast material |
402 |
331 |
$92K |
| 87486 |
|
1,981 |
1,837 |
$89K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,687 |
692 |
$89K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,457 |
2,256 |
$86K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,067 |
1,020 |
$80K |
| 36415 |
Collection of venous blood by venipuncture |
44,702 |
35,335 |
$63K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
622 |
423 |
$62K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
981 |
926 |
$60K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,446 |
23,676 |
$60K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,906 |
1,650 |
$53K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
360 |
289 |
$44K |
| 87581 |
|
1,982 |
1,838 |
$43K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
1,088 |
762 |
$41K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,916 |
561 |
$39K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
329 |
284 |
$34K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,982 |
1,838 |
$28K |
| 84484 |
|
1,783 |
1,236 |
$26K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
224 |
212 |
$25K |
| 97533 |
|
335 |
104 |
$24K |
| 81514 |
|
134 |
127 |
$18K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
165 |
144 |
$18K |
| 86592 |
|
990 |
877 |
$17K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,793 |
1,546 |
$16K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
420 |
259 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,448 |
1,275 |
$15K |
| 85027 |
|
1,217 |
1,006 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
250 |
233 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,102 |
968 |
$9K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
16 |
12 |
$9K |
| 80074 |
|
362 |
317 |
$9K |
| 86703 |
|
689 |
608 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
3,150 |
2,560 |
$7K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
354 |
327 |
$6K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
192 |
172 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,503 |
2,812 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
466 |
368 |
$6K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
39 |
36 |
$6K |
| 73630 |
|
91 |
73 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
106 |
80 |
$5K |
| A0425 |
Ground mileage, per statute mile |
3,182 |
2,276 |
$5K |
| 80061 |
Lipid panel |
613 |
525 |
$5K |
| 85007 |
|
832 |
686 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
124 |
112 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
781 |
724 |
$4K |
| 96415 |
|
18 |
13 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,186 |
1,014 |
$4K |
| 83615 |
|
1,759 |
1,140 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
93 |
44 |
$3K |
| 87653 |
|
75 |
71 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
893 |
638 |
$3K |
| 86850 |
|
332 |
298 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,156 |
4,170 |
$3K |
| 86762 |
|
234 |
212 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
18 |
12 |
$3K |
| 36591 |
|
275 |
148 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
9,020 |
5,260 |
$2K |
| 80055 |
|
60 |
58 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
113 |
97 |
$2K |
| 80320 |
|
14 |
13 |
$2K |
| 93017 |
|
32 |
25 |
$2K |
| 62323 |
|
17 |
12 |
$2K |
| 80076 |
|
117 |
103 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,749 |
2,502 |
$1K |
| 73562 |
|
31 |
25 |
$1K |
| 86900 |
|
331 |
291 |
$1K |
| 81001 |
|
8,916 |
7,513 |
$1K |
| 82950 |
|
193 |
180 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
182 |
152 |
$1K |
| 36000 |
|
472 |
267 |
$1K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
448 |
142 |
$967.79 |
| 87077 |
|
102 |
94 |
$864.21 |
| 93975 |
|
26 |
24 |
$804.19 |
| 87340 |
|
127 |
111 |
$757.29 |
| 83735 |
|
365 |
286 |
$647.40 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
51 |
47 |
$455.81 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,165 |
980 |
$420.00 |
| 84439 |
|
31 |
26 |
$419.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,881 |
1,600 |
$374.08 |
| 86803 |
|
96 |
85 |
$342.57 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
72 |
51 |
$314.47 |
| J3490 |
Unclassified drugs |
52 |
25 |
$313.72 |
| 84703 |
|
1,645 |
1,405 |
$304.17 |
| 94761 |
|
727 |
395 |
$233.45 |
| 85379 |
|
44 |
37 |
$215.30 |
| 83690 |
|
3,613 |
3,056 |
$207.91 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
33 |
31 |
$207.72 |
| 82728 |
|
14 |
12 |
$204.70 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
14 |
12 |
$150.71 |
| 71046 |
Radiologic examination, chest; 2 views |
342 |
319 |
$128.12 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
94 |
84 |
$111.43 |
| G0378 |
Hospital observation service, per hour |
47 |
37 |
$97.20 |
| G0008 |
Administration of influenza virus vaccine |
24 |
15 |
$72.66 |
| 85660 |
|
13 |
12 |
$65.79 |
| J2704 |
Injection, propofol, 10 mg |
2,052 |
1,742 |
$53.04 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
890 |
790 |
$51.51 |
| 36416 |
|
20 |
18 |
$49.64 |
| 82077 |
|
215 |
162 |
$47.30 |
| 80305 |
|
153 |
119 |
$44.75 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
31 |
12 |
$41.13 |
| 84145 |
|
28 |
26 |
$31.56 |
| 82043 |
|
15 |
12 |
$30.42 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
266 |
126 |
$23.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
23 |
$22.48 |
| 85610 |
|
77 |
37 |
$19.52 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
13 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
157 |
147 |
$0.00 |
| 92557 |
|
13 |
13 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
13 |
13 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
202 |
162 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
52 |
39 |
$0.00 |
| 99152 |
|
17 |
15 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
15 |
12 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
40 |
32 |
$0.00 |
| 81002 |
|
21 |
13 |
$0.00 |
| E0445 |
Oximeter device for measuring blood oxygen levels non-invasively |
38 |
30 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$0.00 |
| 96367 |
|
27 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
17 |
12 |
$0.00 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
16 |
13 |
$0.00 |
| T5999 |
Supply, not otherwise specified |
17 |
15 |
$0.00 |
| 81025 |
|
27 |
25 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
21 |
12 |
$0.00 |
| 99347 |
|
19 |
19 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
276 |
159 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,022 |
513 |
$0.00 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
142 |
129 |
$0.00 |
| 88304 |
|
109 |
97 |
$0.00 |
| 87040 |
|
61 |
27 |
$0.00 |
| A4556 |
Electrodes, (e.g., apnea monitor), per pair |
39 |
31 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
99 |
91 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
125 |
102 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
19 |
13 |
$0.00 |
| 94760 |
|
103 |
59 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
13 |
12 |
$0.00 |
| 86140 |
|
51 |
42 |
$0.00 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
88 |
42 |
$0.00 |
| 97162 |
|
19 |
17 |
$0.00 |
| 92567 |
|
15 |
15 |
$0.00 |
| 88342 |
|
39 |
26 |
$0.00 |
| 93000 |
|
12 |
12 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$0.00 |